People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pattern Bioscience, Inc. | — | Biotechnology | Series C | $83.7M | $260.9M | 2018 |
Bryan Gammon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bryan Gammon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nicholas Naclerio | 1 | 5 |
| Patrick Balthrop | 1 | 3 |
| Greg Wood | 1 | 2 |
| Scott Mendel | 1 | 2 |
| Ross Johnson | 1 | 1 |
| Bryan B. Gammon | 1 | 1 |
| Gregory J. Wood | 1 | 1 |
| Oscar B. Marx III | 1 | 1 |
| Patrick J. Balthrop, Sr. | 1 | 1 |
| Johnson Ross | 1 | 1 |
| Gregory Wood | 1 | 1 |
| Oscar Marx | 1 | 1 |
| Junjun Gao | 1 | 1 |
| Nicolas Arab | 1 | 1 |
| Carey-Ann Burnham | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.